Nutritional Tolerance and Safety of a Tube Feeding Formula in Children

NCT05838495 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2024-11-06

No results posted yet for this study

Summary

To assess the efficacy, tolerance, and safety of a pediatric enteral formula in children.

Conditions

  • Enteral Feeding

Interventions

OTHER

formulated liquid diet

will be fed exclusively the pediatric enteral study formula with a feeding tube

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Jessie Hulst, MD · The Hospital for Sick Children

  • Cindy Steel, MSc · Nestle Health Science Canada

  • Krys Araujo Torres, MD · Nestle Health Science USA

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Year
Max Age
13 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2024-07-05
Completion
2024-07-06

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05838495 on ClinicalTrials.gov